Results 31 to 40 of about 414,143 (313)
Frontiers in Public Health, 2018 BackgroundPolicy makers face a lot of challenges in the process of drug reimbursement decision-making, especially in the context of entering the market of more and more innovative medicinal products (MPs).
Maria Kamusheva +6 more
doaj +1 more source
Improving the Lives of Young Children: Increasing Referrals and Follow-Up Treatment in Medicaid and CHIP [PDF]
, 2010 Outlines factors limiting referrals and treatment for children in public insurance programs, including low reimbursement rates and complex billing rules and fragmentation between primary care and treatment providers.
Genevieve M. Kenney +1 more
core +1 more source
Waiting for reimbursement [PDF]
Science, 2019 It has been an exciting and productive conference. As a fifth-year Ph.D. student, I am less nervous when I present my work than I used to be, and I finally feel I fit in as a scholar. But when my abstract was accepted in the fall, I had to consider something completely unrelated to my science: whether I could afford to go.
openaire +2 more sources
Human Resources for Health, 2019 Background Ischaemic stroke care requires a co-ordinated multi-disciplinary approach to optimise patient outcomes. Current care provision in Saudi Arabia is below international recommendations, and with increasing patient numbers, variable access to new ...
Fahmi Al-Senani +5 more
doaj +1 more source
BMC Health Services Research, 2018 Background To describe the demographic and clinical characteristics of Type 1 diabetes (T1D) patients affiliated with the Mexican Institute of Social Security (IMSS) and ascertain the socio-demographic and clinical risk factors associated with emergency ...
Svetlana V. Doubova +5 more
doaj +1 more source
Remote Monitoring in Myasthenia Gravis: Exploring Symptom Variability
Annals of Clinical and Translational Neurology, EarlyView.ABSTRACT Background Myasthenia gravis (MG) is a rare, autoimmune disorder characterized by fluctuating muscle weakness and potential life‐threatening crises. While continuous specialized care is essential, access barriers often delay timely interventions. To address this, we developed MyaLink, a telemedical platform for MG patients.
Maike Stein +13 more
wiley +1 more source
Annals of Clinical and Translational Neurology, EarlyView.ABSTRACT Background Accessing brain magnetic resonance imaging (MRI) can be challenging, especially for underserved patients, which may lead to disparities in neurological diagnosis. Method This mixed‐methods study enrolled adults with one of four neurological disorders: mild cognitive impairment or dementia of the Alzheimer type, multiple sclerosis ...
Maya L. Mastick +19 more
wiley +1 more source
A Case Study of an Agency\u27s Three Family Preservation Contracts [PDF]
, 2002 This article presents a case study of a nonprofit child welfare agency that delivered family preservation services under three different purchase-of-service (POS) contracts.
Ezell, Mark
core +1 more source
A comparison of reimbursement recommendations by European HTA agencies : Is there opportunity for further alignment? [PDF]
, 2017 Introduction: In Europe and beyond, the rising costs of healthcare and limited healthcare resources have resulted in the implementation of health technology assessment (HTA) to inform health policy and reimbursement decision-making.
Allen +13 more
core +3 more sources
Efficacy of Inebilizumab in N‐MOmentum Trial Participants With or Without Prior Immunosuppressants
Annals of Clinical and Translational Neurology, EarlyView.ABSTRACT This post hoc analysis examined the impact of prior immunosuppressants on the long‐term efficacy and safety of inebilizumab, a cluster of differentiation 19+ B‐cell–depleting monoclonal antibody, in participants with aquaporin‐4–seropositive neuromyelitis optica spectrum disorder from the N‐MOmentum trial (NTC02200770).
Bruce A. C. Cree +9 more
wiley +1 more source